Search research articles
Contact Us
Filters
Showing results (51-60 of 174) with videos related to
Page
of 18
Sort By:
Critical Reviews in Oncology/Hematology
|
January 15, 2013
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis
Mario Mandalà, Stefano Fagiuoli, Daniela Francisci, et al.
Critical Reviews in Oncology/Hematology
|
July 28, 2004
Rectal cancer
Maria Giulia Zampino, Roberto Labianca, Giordano Beretta, et al.
International Journal of Oncology
|
April 3, 2013
A randomized phase II non-comparative study of pemetrexed‑carboplatin and gemcitabine‑vinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients
Dino Amadori, Eva Carrasco, Siegfried Roesel, et al.
Tumori
|
March 10, 2010
Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey
Fausto Roila, Enzo Ballatori, Roberto Labianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2011
Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib
Tommaso M De Pas, Monica Giovannini, Michela Manzotti, et al.
Journal of Medical Ethics
|
June 13, 2015
Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research
Gianfranco De Feo, Luciano Frontini, Silvia Rota, et al.
Cancer
|
January 11, 2005
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma
Filippo De Marinis, Fabrizio Nelli, Marco Lombardo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2002
Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial
Stefano Cascinu, Vincenzo Catalano, Luigi Cordella, et al.
Cancer Chemotherapy and Pharmacology
|
September 8, 2010
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
Stefano Cascinu, Eva Galizia, Roberto Labianca, et al.
Health and Quality of Life Outcomes
|
February 7, 2006
Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients
Giovanni Apolone, Oscar Bertetto, Augusto Caraceni, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 174) with videos related to
Sort By:
Page
of 18
Critical Reviews in Oncology/Hematology
|
January 15, 2013
Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis
Mario Mandalà, Stefano Fagiuoli, Daniela Francisci, et al.
Critical Reviews in Oncology/Hematology
|
July 28, 2004
Rectal cancer
Maria Giulia Zampino, Roberto Labianca, Giordano Beretta, et al.
International Journal of Oncology
|
April 3, 2013
A randomized phase II non-comparative study of pemetrexed‑carboplatin and gemcitabine‑vinorelbine in anthracycline- and taxane-pretreated advanced breast cancer patients
Dino Amadori, Eva Carrasco, Siegfried Roesel, et al.
Tumori
|
March 10, 2010
Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey
Fausto Roila, Enzo Ballatori, Roberto Labianca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2011
Large-cell neuroendocrine carcinoma of the lung harboring EGFR mutation and responding to gefitinib
Tommaso M De Pas, Monica Giovannini, Michela Manzotti, et al.
Journal of Medical Ethics
|
June 13, 2015
Time required to start multicentre clinical trials within the Italian Medicine Agency programme of support for independent research
Gianfranco De Feo, Luciano Frontini, Silvia Rota, et al.
Cancer
|
January 11, 2005
A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma
Filippo De Marinis, Fabrizio Nelli, Marco Lombardo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 15, 2002
Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial
Stefano Cascinu, Vincenzo Catalano, Luigi Cordella, et al.
Cancer Chemotherapy and Pharmacology
|
September 8, 2010
Pegylated liposomal doxorubicin, 5-fluorouracil and cisplatin versus mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer: a randomized phase II trial
Stefano Cascinu, Eva Galizia, Roberto Labianca, et al.
Health and Quality of Life Outcomes
|
February 7, 2006
Pain in cancer. An outcome research project to evaluate the epidemiology, the quality and the effects of pain treatment in cancer patients
Giovanni Apolone, Oscar Bertetto, Augusto Caraceni, et al.
Page
of 18